Ignite Creation Date:
2024-05-05 @ 9:35 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005645
Status:
WITHDRAWN
Last Update Posted:
2018-09-18
First Post:
2000-05-02
Brief Title:
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Fallopian Tube Cancer |
| Metastatic Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| primary peritoneal cavity cancer | View |
| stage III ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| recurrent ovarian epithelial cancer | View |
| liver metastases | View |
| malignant pericardial effusion | View |
| malignant pleural effusion | View |
| malignant ascites | View |
| fallopian tube cancer | View |